Yahoo Finance Plus 
A gene editing firm has added $50 million to its coffers shortly after landing a significant development agreement with a global pharmaceutical company.
The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...
The last few years saw the markets go crazy. Between the COVID lockdowns and market crash, the rebound recovery, last year’s sustained bull run, and this year’s devastating first half that saw the bull turn into a bear. But in all of that, there have been stocks that have outperformed the market. These winning stocks have attracted attention from Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program. Among other things, Cramer has been following stocks which won big during the COVID cris
After disruptions at GSK plc (NYSE: GSK), supplies of rotavirus infection vaccine in children have either run out in Kenya, Tanzania, Senegal, and Cameroon or are close, Reuters reported citing officials close to the roll-out. According to the World Health Organization, up to 200,000 children die each year of contagious infection. The infection causes severe, dehydrating gastroenteritis in children under five years. GSK confirmed a shortfall of around 4 million doses of its Rotarix vaccine in 20
Persistent supply issues have deflated expectations for the Chinese automaker
Hut 8 Mining Corp. (Nasdaq: HUT) (TSX: HUT), ("Hut 8" or the "Company") one of North America's largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure provider, is pleased to announce its financial results for the quarter ended June 30, 2022. All dollar figures are in Canadian Dollars ("CAD"), unless otherwise stated.
Investors like getting a return on investment, of course, it’s why they are in the market to begin with. And when a company makes a commitment to return capital and profits to the shareholders, that’s a win – one that will both attract and reward investors. The key for investors is to find the best possible capital return, and dividend stocks make a logical place to start looking. With this in mind, we’ve used the TipRanks database to pull up the details on two true dividend aristocrats – real c
Choosing stocks that can weather the storm and do well afterward, too, are the kinds of companies we should seek out, and the following trio of top tech stocks should outperform no matter what the market throws at it. Having shed its Warner Media division into the newly reconstituted Warner Bros Discovery in April, AT&T (NYSE: T) is now able to focus solely on its telecom operations and the rollout of its 5G network that will provide the industry with its next wave of growth. Although AT&T says it's not immune from the recessionary impacts affecting the broader economy, it's capable of managing through them and investing for the long-term benefit of customers and investors.
Among the dozens of stocks to enact splits this year are two industry leaders that scream value and one cash-rich company that's clobbering its shareholders.
While every market advisor will tell you never to try to ‘time’ the market, timing is still important for success. Investors need to buy into low prices, and to do that, they need to know when prices are low. This doesn’t necessarily mean low in absolute dollar terms, but low relative to a stock’s recent past performance. In recognizing that lower price range, investors can turn to Wall Street’s pros for help. The analysts have been busy lately, picking out stocks that are in their lower price r
(Bloomberg) -- Sanofi, GSK Plc and Haleon Plc extended their declines and have lost a combined $40 billion in market value since Tuesday’s close amid mounting concerns about litigations around recalled heartburn drug Zantac.Most Read from BloombergMusk Sells Another $6.9 Billion of Tesla Ahead of Twitter TrialDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsMedia Counts Differ With 11 Million Votes Collated: Kenya UpdateUS Inflation Runs Cooler Than Forecast, Easing Pressure on
Technology stocks have been among the best-performing sectors over the past month, second only to consumer discretionary stocks. Admittedly, the tech-laden Nasdaq 100 index is still down 19% in 2022, compared to a 13% decline in the S&P 500 and a 9% drop in the Dow Jones Industrial Average, but the rally indicates the sector is not dead. Tech stocks carried the market on its nearly decade-and-a-half bull run before they were frozen out at the end of last year as traders switched to seemingly more recession-resistant names.
The mercurial stock is down after earnings, but there is still plenty of reason for optimism for long-term investors.
The Senior Citizens League projects the annual cost-of-living adjustment for 2023 to come in at 9.6%, down slightly from the prior month's estimate as inflation cooled a bit.
The housing market is changing fast. Act accordingly.
Yahoo Finance Live anchor Akiko Fujita examines several trending stocks making moves in after hours trading.
One of the big advantages of owning certain real estate investment trusts (REITs) over common stock is this: Some pay dividends monthly. Stocks pay dividends quarterly, which is nice, but monthly sounds better to more than a few investors. With that in mind, here are five REITs paying the monthly dividends. 1. Agree Realty Corp. (NYSE: ADC) pays a 3.61% annualized dividend and trades on the New York Stock Exchange with an average daily volume of 815,000 shares. The monthly dividend payment is $0
Yahoo Finance Live's Rachelle Akuffo reports on the FCC rebuffing SpaceX's bid for rural broadband subsidies.
Four years after Siga Technologies (Nasdaq: SIGA) gained approval for a smallpox drug, the Corvallis company is gearing up to get the same antiviral into a clinical trial for monkeypox. Tpoxx, also known as tecovirimat, is the only drug available to treat the virus, though it is not yet approved in the U.S. for the disease. The Food and Drug Administration designated Tpoxx as an investigational drug for monkeypox, allowing it to be released from the Strategic National Stockpile only after prescribers jump through considerable hoops.
Coupang, Inc. (CPNG) delivered earnings and revenue surprises of 63.64% and 2.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Not even a bear market decline can faze billionaire money managers who are intent on owning innovative companies and future industry leaders.
Yahoo Finance